FLI1 and invasive breast carcinoma: The potential mechanism of the effect of FLI1 on cell–cell crosstalk by targeting immune-related ligands and receptors is shown in Fig. 5H. The FLI1 is mainly expressed in endothelial cells, T cells, and myeloid cells in BRCA tissues and corresponding normal tissues.